Month: June 2021

Singapore, June 18, 2021 — MIMO, the governance token behind Mimo DeFi, has officially been listed on Bittrex Global. In addition, PAR – Mimo’s stable token which is algorithmically pegged to the Euro — has also been listed. Its appeal to users of Bittrex comes from both owning the platform Mimo is built on as well as utilizing their native currency for those located in Europe. This marks Mimo’s largest centralised exchange listing to date and enables a wider audience to trade the MIMO & PAR tokens. PAR is exclusively minted in relation to loans on Mimo DeFi, the beginner-friendly lending platform that MIMO token holders help govern. PAR tokens are therefore collateralized by assets accepted on Mimo DeFi. Nick Calabro, Growth Manager at Mimo, says that joining the Bittrex lineup is just the first step in a series of bullish...

OSLO, Norway (21 June 2021) – TGS, a global provider of energy data and intelligence, today announced Sophies Resolve Refocus 3D, an OBC and NAZ imaging program in the U.S. Gulf of Mexico. The program includes approximately 6,175 square kilometers of reprocessed 3D seismic data to provide a high-quality regional product, helping E&Ps further explore new and existing plays in this area. Sophies Resolve Refocus 3D marks the next phase of high-quality imaging over the mature, hydrocarbon-producing areas of South Timbalier, Grand Isle and Ewing Bank. By applying advanced imaging techniques utilizing its proprietary Dynamic Matching FWI imaging technology in this highly successful region, TGS will further illuminate the key subsurface structures and provide new insight into the prospectivity within the deeper sub-salt section. Additionally,...

TORONTO, June 20, 2021 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “company”) (TSX, NYSE: HBM) today announced that a fatality occurred at its Lalor mine, located in Snow Lake, Manitoba. The incident occurred during underground mining operations on the evening of June 19, 2021, when a worker employed by a service provider was fatally injured from a fall while working at height. No other personnel were injured and the scene has been secured. All underground mining operations at the Lalor mine have been suspended while an investigation is completed. “This is a tragic situation and we are profoundly saddened by this unfortunate incident. Our hearts go out to the individual’s family, friends and colleagues during this difficult time,” said Peter Kukielski, Hudbay’s President and Chief Executive Officer. “The safety and...

The Annual General Meeting of Festi held 22 March 2021 empowered the Board of Directors, pursuant to Article 55 of the Company Act No 2/1995, to purchase in the next 12 months upto 10% of the company‘s shares on its behalf. The purpose of the program is to decrease the number of issued shares. The Board of Directors of Festi has on the basis of the mandate issued by the Annual General Meeting adopted a decision on the execution of a buy-back program. The aim is to buy back own shares for the maximum amount of 2,090,623 shares or 0,65% of issued shares, the total amount of the buy-back however not exceeding 430,000,000 ISK in total purchase price. The buy-back will be executed in stages, with the maximum amount of shares purchased per day are set at 250,000 shares equivalent to 20% of the average daily trade in the company‘s shares on Nasdaq...

The stock market is an immense framework where publicly traded companies trade their outstanding shares at market. Shares are issued and sold at a designated market price which is to be considered the representation of fair value in exchange for monetary value to the investor and intended shareholder. The investor purchases believing the asset will hold greater future value than that being traded and offered in price today. Another factor the investor should be acutely aware of is making sure purchase and sale is based on price and at a time in which reduces the prospect of investing or holding an asset about to experience any period of uncertainty likely to become a reality. Shares are bought and for a period of time held, before typically being later sold back to market with a view to sharing in the capital increase seen in price change....

VANCOUVER, British Columbia, June 19, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has commenced the development of a next-generation psychedelic drug formulation for the purpose of mitigating neurological damage that results from ischemic strokes. Akome’s next generation psychedelic drug formulation for the mitigation of neurological damage resulting from ischemic strokes, also known as AKO001, is comprised of the psychedelic compound N,N-dimethyltryptamine (DMT) and a specific plant bioactive which, when combined together, are believed to work in a complementary and mitigating manner when provided to individuals immediately following their ischemic stroke. A provisional matter...

PETALING JAYA, Malaysia, June 18, 2021 (GLOBE NEWSWIRE) — Eostre Berhad, a majority-owned subsidiary of Toga Limited (OTC: TOGL), has been officially appointed by China’s Shenzhen Shengquan Biotechnology Co., Ltd., as its exclusive worldwide distributor for its product, the “H2O Energy Bottle”. Eostre is now tasked with developing a world-wide market for the “H2O energy bottles”. “We are pleased to establish this collaboration between Shenzhen Shengquan Biotechnology and Eostre. This collaboration will further grow Eostre’s product range and customer base globally,” said Eostre Berhad General Manager, Ms. Low Kah Fong. “We anticipate both companies will jointly expand the awareness and demand for the H2O energy bottle. This is also seen as being in line with Eostre’s vision of becoming an international brand with world-leading...

PARIS and Cambridge, Mass., June 19, 2021 (GLOBE NEWSWIRE) — Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces a new line of financing through Bonds Redeemable in Cash and New and Existing Shares (ORNANE) with Atlas, a specialized investment fund based in New York (United States), for €32 million (the “2021 Atlas Contract”). This line of financing will be used for further clinical development of Sarconeos (BIO101) in sarcopenia following our SARA phase 2 results and for...